Çeşitli böbrek hastalığı olan çocuklarda gentamisinin, N-asetil-beta-D-glukozaminidazın, beta-2 mikroglobulinin, mikroalbuminin ve biyokimyasal parametrelerin değişimlerinin incelenmesi
Study of gentamicin, -acetyl-beta-D- glucosaminidase, beta-2 microglobulin, microalbumin and biochemical parameters changes in different pediatric kidney diseases
- Tez No: 27719
- Danışmanlar: DOÇ. DR. FİKRET VEHBİ İZZETTİN
- Tez Türü: Doktora
- Konular: Biyokimya, Biochemistry
- Anahtar Kelimeler: Albüminüri, Asetilglükozaminidaz, Beta 2 mikroglobülin, Böbrek hastalıkları, Gentamisinler, Albuminuria, Acetylglucosaminidase, Beta 2 microglobulin, Kidney diseases, Gentamicins
- Yıl: 1993
- Dil: Türkçe
- Üniversite: Marmara Üniversitesi
- Enstitü: Sağlık Bilimleri Enstitüsü
- Ana Bilim Dalı: Biyokimya Ana Bilim Dalı
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
135 VII. SUMMARY STUDY OF GENTAMICIN, N-ACETYL-BETA-D-GLUCOSAMINIDASE, BETA-2 MICROGLOBULIN, MICROALBUMIN AND BIOCHEMICAL PARAMETERS CHANGES IN DIFFERENT PEDIATRIC KIDNEY DISEASES This study was conducted to study the importance of different biochemical parameters, N-acetyl-jS-D-glucosaminidase, beta-2 microglobu lin and microalbumin in early detection and monitoring of patients with different pediatric kidney diseases. Fifty-four pediatric patients with various kidney diseases were followed in this study: 20 patients with Acute glomerulonephritis, 8 pati ents with Nephrotic syndrome, 5 patients with Henoch-Schönlein nephritis and 21 patients with Urinary tract infections. The data indicate N-a- cetyl-/3-D-glucosaminidase and beta-2 microglobulin are good indicators for various kidney diseases compared to biochemical parameters and mic roalbumin. The level of N-acetyl-j3-D-glucosaminidase in urine measured colorimetrically and its level before treatment are significantly higher than control group (1.85±0. 30 U/L; 2.44±0.68 U/g urine creatinine). The urine level of N-acetyl-/J-D-glucosominidase before treatment were as follows (Mean+SD): Acute glomerulonephritis (7.88±6.64 U/L; 14.74±12.00 U/g136 urine creatinine), Nephrotic syndrome (15.51±8.92 U/L; 32.93+22.45 U/g urine creatinine), Henoch-Schönlein nephritis (8.62+2.25 U/L; 24. 94± 13.76 U/g urine creatinine), Urinary tract infection (6.94 + 4.08 U/L; 15.88+13.83 U/g urine creatinine). The urine level of beta-2 microglobulin measured by immunoradi- ometric assay method. The level of beta-2 microglobulin are significantly higher than control group (21.50±4.48 ng/ml, 29.52±6.78 ng/mg urine cre atinine). The urine level of beta-2 microglobulin before treatment were as follows (MeaniSD): Acute glomerulonephritis (54.55+38.06 ng/ml; 110.74±67.82 ng/mg urine creatinine), Nephrotic syndrome (235.00±150.99 ng/ml; 521.47+383.40 ng/mg urine creatinine). Henoch-Sc hönlein nephritis (42.40+8.98 ng/ml; 127.80178.31 ng/mg urine creatini ne), Urinary tract infection (120.23±80.20 ng/ml; 33.71±15.46 ng/mg uri ne creatinine). In this study the level of gentamicin monitored in 21 patients with urinary tract infection treated with gentamicin 5 mg/kg/I.M showed serum level within therapeutic level (2-10 /zg/ml). As a conclusion due to higher stability of N-acetyl-/î-D-glucosa- minidase in urine and absence of diurnal variation of excretion of N-a- cetyl-0-D-glucosaminidase suggest the analysis of N-acetyl-/?-D-glucosami- nidase in determination and following of pediatrics patients with different kidney disease better than beta-2 microglobulin. Also this stuy indicate the importance of monitoring of gentamicin level to prevent nephrotoxicity and ototoxicity in pediatric therapy.
Özet (Çeviri)
135 VII. SUMMARY STUDY OF GENTAMICIN, N-ACETYL-BETA-D-GLUCOSAMINIDASE, BETA-2 MICROGLOBULIN, MICROALBUMIN AND BIOCHEMICAL PARAMETERS CHANGES IN DIFFERENT PEDIATRIC KIDNEY DISEASES This study was conducted to study the importance of different biochemical parameters, N-acetyl-jS-D-glucosaminidase, beta-2 microglobu lin and microalbumin in early detection and monitoring of patients with different pediatric kidney diseases. Fifty-four pediatric patients with various kidney diseases were followed in this study: 20 patients with Acute glomerulonephritis, 8 pati ents with Nephrotic syndrome, 5 patients with Henoch-Schönlein nephritis and 21 patients with Urinary tract infections. The data indicate N-a- cetyl-/3-D-glucosaminidase and beta-2 microglobulin are good indicators for various kidney diseases compared to biochemical parameters and mic roalbumin. The level of N-acetyl-j3-D-glucosaminidase in urine measured colorimetrically and its level before treatment are significantly higher than control group (1.85±0. 30 U/L; 2.44±0.68 U/g urine creatinine). The urine level of N-acetyl-/J-D-glucosominidase before treatment were as follows (Mean+SD): Acute glomerulonephritis (7.88±6.64 U/L; 14.74±12.00 U/g136 urine creatinine), Nephrotic syndrome (15.51±8.92 U/L; 32.93+22.45 U/g urine creatinine), Henoch-Schönlein nephritis (8.62+2.25 U/L; 24. 94± 13.76 U/g urine creatinine), Urinary tract infection (6.94 + 4.08 U/L; 15.88+13.83 U/g urine creatinine). The urine level of beta-2 microglobulin measured by immunoradi- ometric assay method. The level of beta-2 microglobulin are significantly higher than control group (21.50±4.48 ng/ml, 29.52±6.78 ng/mg urine cre atinine). The urine level of beta-2 microglobulin before treatment were as follows (MeaniSD): Acute glomerulonephritis (54.55+38.06 ng/ml; 110.74±67.82 ng/mg urine creatinine), Nephrotic syndrome (235.00±150.99 ng/ml; 521.47+383.40 ng/mg urine creatinine). Henoch-Sc hönlein nephritis (42.40+8.98 ng/ml; 127.80178.31 ng/mg urine creatini ne), Urinary tract infection (120.23±80.20 ng/ml; 33.71±15.46 ng/mg uri ne creatinine). In this study the level of gentamicin monitored in 21 patients with urinary tract infection treated with gentamicin 5 mg/kg/I.M showed serum level within therapeutic level (2-10 /zg/ml). As a conclusion due to higher stability of N-acetyl-/î-D-glucosa- minidase in urine and absence of diurnal variation of excretion of N-a- cetyl-0-D-glucosaminidase suggest the analysis of N-acetyl-/?-D-glucosami- nidase in determination and following of pediatrics patients with different kidney disease better than beta-2 microglobulin. Also this stuy indicate the importance of monitoring of gentamicin level to prevent nephrotoxicity and ototoxicity in pediatric therapy.
Benzer Tezler
- Kronik böbrek hastalığı olan çocuklarda ağız diş sağlığı durumunun değerlendirilmesi
Evaluation of the oral and dental health status in children withchronic kidney disease
ÖZGE BEKTAŞ
Diş Hekimliği Uzmanlık
Türkçe
2019
Diş HekimliğiHacettepe ÜniversitesiÇocuk Diş Hekimliği Ana Bilim Dalı
DR. ÖĞR. ÜYESİ TÜLİN İLERİ KEÇELİ
- Kronik böbrek hastalığı olan çocuklarda bağırsak mikroflorası ile anemi ve inflamatuvar belirteçler arasındaki ilişkinin incelenmesi
Investigation of the relationship between gut microbiota, anemia, and inflammatory markers in children with chronic kidney disease
SİMGE IŞILDAK
Tıpta Uzmanlık
Türkçe
2025
Çocuk Sağlığı ve HastalıklarıMarmara ÜniversitesiÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
PROF. DR. NURDAN YILDIZ
- Oral health status in a group of children with chronic kidney disease
Kronik böbrek hastalığı olan çoçuklarda ağız sağlığı durumu
ANİTA MİSZTALEWSKA
Yüksek Lisans
İngilizce
2016
NefrolojiMarmara ÜniversitesiPedodonti Ana Bilim Dalı
PROF. DR. ŞEMSA İLKNUR TANBOĞA
PROF. DR. IŞIN ULUKAPI
- Kronik böbrek hastalığı olan çocuk hastalarda ağız-diş sağlığının değerlendirilmesi
Assessment of the oral health status of children with chronic kidney disease
NUR KODAMAN DOKUMACIGİL
Doktora
Türkçe
2024
Diş HekimliğiMarmara ÜniversitesiPedodonti Ana Bilim Dalı
PROF. DR. BETÜL KARGÜL
PROF. DR. NEVZAT EŞBER ÇAĞLAR
- COVID-19 salgın sürecinin kronik böbrek hastalığı olan çocuklara etkisinin değerlendirilmesi
Evaluation of the impact of the COVID-19 pandemic on children with chronic kidney diseases
BEDİRHAN SATICI
Tıpta Uzmanlık
Türkçe
2023
Çocuk Sağlığı ve HastalıklarıAkdeniz ÜniversitesiÇocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
PROF. DR. ELİF ÇOMAK